(Q34495274)

English

Bone marrow biopsy: RNA isolation with expression profiling in men with metastatic castration-resistant prostate cancer--factors affecting diagnostic success

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Bone marrow biopsy: RNA isolation with expression profiling in men with metastatic castration-resistant prostate cancer--factors affecting diagnostic success (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Charles E Spritzer

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

P Diana Afonso

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Emily N Vinson

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

James D Turnbull

4

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Karla K Morris

5

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Adam Foye

6

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

John F Madden

7

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Kingshuk Roy Choudhury

8

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Phillip G Febbo

9

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Daniel J George

10

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

language of work or name

0 references

publication date

28 October 2013

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

269

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

816-823

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Emerging treatment options for patients with castration-resistant prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4228710

6 July 2018

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4228710

6 July 2018

EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4228710

6 July 2018

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4228710

6 July 2018

Bone and soft-tissue lesions: what factors affect diagnostic yield of image-guided core-needle biopsy?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4228710

6 July 2018

CT-guided biopsy of bone: a radiologist's perspective

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4228710

6 July 2018

Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4228710

6 July 2018

Acetic acid-zinc-formalin: a safe alternative to B-5 fixative

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4228710

6 July 2018

The molecular genetics of prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4228710

6 July 2018

A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4228710

6 July 2018

The percutaneous needle biopsy is safe and recommended in the diagnosis of musculoskeletal masses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4228710

6 July 2018

Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4228710

6 July 2018

MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4228710

6 July 2018

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4228710

6 July 2018

Percutaneous bone biopsy, techniques and indications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4228710

6 July 2018

Image-guided percutaneous biopsy of musculoskeletal tumors: an algorithm for selection of specific biopsy techniques

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4228710

6 July 2018

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4228710

6 July 2018

Percutaneous biopsy of skeletal lesions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4228710

6 July 2018

Percutaneous needle biopsy of musculoskeletal lesions. 2. Cost-effectiveness

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4228710

6 July 2018

CT-guided needle biopsies of bone and soft tissue tumors: a pathologist's perspective.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4228710

27 October 2018

Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4228710

27 October 2018

PTEN/MMAC1 mutations in prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4228710

27 October 2018

Accuracy of CT-guided biopsies in 359 patients with musculoskeletal lesions.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4228710

27 October 2018

Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4228710

27 October 2018

CT-guided percutaneous biopsy of sclerotic bone lesions: diagnostic yield and accuracy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4228710

27 October 2018

A cost minimization approach to the diagnosis of skeletal neoplasms.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4228710

27 October 2018

Percutaneous needle biopsy of musculoskeletal lesions. 1. Effective accuracy and diagnostic utility

1 reference

https://pubmed.ncbi.nlm.nih.gov/23925271

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Contribution of percutaneous biopsy to the definite diagnosis in patients with suspected bone tumor

1 reference

https://pubmed.ncbi.nlm.nih.gov/23925271

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

10q23.3 loss of heterozygosity is higher in lymph node-positive (pT2-3,N+) versus lymph node-negative (pT2-3,N0) prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23925271

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues

1 reference

https://pubmed.ncbi.nlm.nih.gov/23925271

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary bone tumors: percutaneous needle biopsy. Radiologic-pathologic study of 222 biopsies

1 reference

https://pubmed.ncbi.nlm.nih.gov/23925271

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1148/RADIOL.13121782

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34495274&oldid=1956517793"